Cerus Corporation (CERS)
NASDAQ: CERS · Real-Time Price · USD
1.800
+0.110 (6.51%)
At close: Mar 16, 2026, 4:00 PM EDT
1.846
+0.046 (2.57%)
After-hours: Mar 16, 2026, 7:52 PM EDT
Cerus Revenue
In the year 2025, Cerus had annual revenue of $233.80M with 16.13% growth. Cerus had revenue of $64.58M in the quarter ending December 31, 2025, with 13.79% growth.
Revenue (ttm)
$233.80M
Revenue Growth
+16.13%
P/S Ratio
1.68
Revenue / Employee
$749,575
Employees
275
Market Cap
345.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 233.80M | 32.48M | 16.13% |
| Dec 31, 2024 | 201.32M | 14.52M | 7.78% |
| Dec 31, 2023 | 186.80M | -1.52M | -0.81% |
| Dec 31, 2022 | 188.32M | 28.80M | 18.05% |
| Dec 31, 2021 | 159.52M | 45.27M | 39.62% |
| Dec 31, 2020 | 114.25M | 20.48M | 21.83% |
| Dec 31, 2019 | 93.77M | 17.72M | 23.30% |
| Dec 31, 2018 | 76.05M | 24.73M | 48.17% |
| Dec 31, 2017 | 51.33M | 12.05M | 30.68% |
| Dec 31, 2016 | 39.28M | 5.05M | 14.76% |
| Dec 31, 2015 | 34.22M | -2.19M | -6.02% |
| Dec 31, 2014 | 36.42M | -3.24M | -8.17% |
| Dec 31, 2013 | 39.66M | 2.87M | 7.80% |
| Dec 31, 2012 | 36.79M | 3.74M | 11.32% |
| Dec 31, 2011 | 33.04M | 9.94M | 42.99% |
| Dec 31, 2010 | 23.11M | 5.13M | 28.51% |
| Dec 31, 2009 | 17.98M | 1.48M | 8.94% |
| Dec 31, 2008 | 16.51M | 5.46M | 49.47% |
| Dec 31, 2007 | 11.04M | -19.27M | -63.56% |
| Dec 31, 2006 | 30.31M | 16.81M | 124.57% |
| Dec 31, 2005 | 13.50M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Varex Imaging | 854.40M |
| Viemed Healthcare | 270.28M |
| OrthoPediatrics | 236.35M |
| Pacific Biosciences of California | 160.01M |
| RxSight | 134.48M |
| Standard BioTools | 85.33M |
| Delcath Systems | 85.23M |
| BrainsWay | 52.23M |
CERS News
- 10 hours ago - Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer - Business Wire
- 11 days ago - Cerus's Record 2025 Sets It Up For Another Leg Higher - Seeking Alpha
- 14 days ago - Cerus Corporation (CERS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results - Business Wire
- 24 days ago - Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference - Business Wire
- 27 days ago - Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026 - Business Wire
- 7 weeks ago - DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus' INTERCEPT™ Blood System in Routine Clinical Practice - Business Wire
- 2 months ago - Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook - Business Wire